Discover Micron's volatile stock trends, strong DRAM demand, and potential recovery by Q4 2025. Learn why NAND oversupply may ...

CEO Kim Kelderman highlighted 9% organic revenue growth for the quarter, driven by strong performance in biopharma end markets, particularly large pharma, which benefited GMP reagents and protein ...

Phase 1: Foundation Throughout Q1 and Q2 2025, the initial phase focuses on laying a robust technological groundwork for the ...

The AFD is managed by the unincorporated Federation Treasury of The United States of America and operates under the strategic guidance of key figures such as Judge Anna and the Global Family Group.

Zacks Small Cap also issued estimates for TuHURA Biosciences’ Q3 2025 earnings at ($0.15) EPS, Q4 2025 earnings at ($0.15) EPS, Q1 2026 earnings at ($0.17) EPS and Q2 2026 earnings at ($0.17 ...

Also, for your calendar planning purposes ... and we'll share more details regarding the financial impact during our Q2 earnings call. Q1 EPS was $0.69, down 22% from the prior year, primarily ...

We'll share more about longer-term strategy as the calendar year progresses ... leverage ratio to decline from seven times in Q1 to 2.7 times in Q2. Now in terms of the tangible benefits of ...

Zacks Research also issued estimates for Caterpillar’s Q4 2025 earnings at $5.70 EPS, FY2025 earnings at $20.81 EPS, Q1 2026 earnings at $5.40 EPS, Q2 2026 earnings at $5.81 EPS, Q3 2026 ...

Additionally, we are very encouraged that in the most recent China market data for calendar year ... in our fiscal Q1 and delivered higher than anticipated shipments in Q2, allowing the release ...

Steve Beauchamp; Co-Chief Executive Officer, Director; Paylocity Holding Corp Toby Williams; President, Co-Chief Executive Officer, Director; Paylocity Holding Corp Good day and welcome to the ...